U.S. Pharmaceuticals
U.S. Pharmaceuticals is listed as the manufacturer on 7 FDA drug label records covering 7 distinct active ingredients predominantly human prescription drug products.
About U.S. Pharmaceuticals
U.S. Pharmaceuticals is named as the labeler on 7 FDA drug label records. Its catalogue spans 7 distinct active ingredients, led by ABROCITINIB, BOSUTINIB, CONJUGATED ESTROGENS/BAZEDOXIFENE, ELRANATAMAB-BCMM. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: treatment adult, breast cancer, advanced metastatic, inhibitor indicated, endocrine therapy, negative locally, pediatric patients, hrr gene-mutated. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| ABROCITINIB | 1 |
| BOSUTINIB | 1 |
| CONJUGATED ESTROGENS/BAZEDOXIFENE | 1 |
| ELRANATAMAB-BCMM | 1 |
| PALBOCICLIB | 1 |
| RITLECITINIB | 1 |
| TALAZOPARIB | 1 |
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | ORAL | 6 |
| — | — | SUBCUTANEOUS | 1 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from U.S. Pharmaceuticals
| Brand name | Generic | Type | Route |
|---|---|---|---|
| BOSULIF | BOSUTINIB | HUMAN PRESCRIPTION DRUG | ORAL |
| CIBINQO | ABROCITINIB | HUMAN PRESCRIPTION DRUG | ORAL |
| Duavee | CONJUGATED ESTROGENS/BAZEDOXIFENE | HUMAN PRESCRIPTION DRUG | ORAL |
| Elrexfio | ELRANATAMAB-BCMM | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| Ibrance | PALBOCICLIB | HUMAN PRESCRIPTION DRUG | ORAL |
| Litfulo | RITLECITINIB | HUMAN PRESCRIPTION DRUG | ORAL |
| Talzenna | TALAZOPARIB | HUMAN PRESCRIPTION DRUG | ORAL |
Frequently asked questions
How many FDA drug products does U.S. Pharmaceuticals make?
7 FDA drug label records name U.S. Pharmaceuticals as the manufacturer, covering 7 distinct active ingredients.
What active ingredients does U.S. Pharmaceuticals produce?
The most frequent active ingredients in this portfolio are ABROCITINIB, BOSUTINIB, CONJUGATED ESTROGENS/BAZEDOXIFENE, ELRANATAMAB-BCMM, PALBOCICLIB.
Are U.S. Pharmaceuticals products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.